Is BDH Industries overvalued or undervalued?
As of October 1, 2025, BDH Industries is considered overvalued with a PE ratio of 30.38 and an EV to EBITDA of 22.08, indicating a premium valuation compared to competitors like Sun Pharma and Cipla, despite its recent strong performance.
As of 1 October 2025, BDH Industries has moved from an expensive to a very expensive valuation grade. The company is currently considered overvalued based on its financial ratios, with a PE ratio of 30.38, a Price to Book Value of 4.21, and an EV to EBITDA of 22.08. These figures indicate a premium valuation compared to its peers in the pharmaceuticals and biotechnology sector.In comparison, Sun Pharma has a PE ratio of 34.22 and an EV to EBITDA of 23.17, while Cipla shows a more attractive PE ratio of 22.63 and an EV to EBITDA of 15.9. The significant disparity in these ratios suggests that BDH Industries is trading at a higher valuation than many of its competitors, reinforcing the conclusion that it is overvalued. Additionally, BDH has outperformed the Sensex in various time frames, including a 60.81% return over the past month, which may have contributed to its inflated valuation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
